14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $3.75 $7.35 Wednesday, 1st May 2024 FATE stock ended at $4.09. This is 3.54% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 11.47% from a day low at $3.88 to a day high of $4.33.
90 days $3.75 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
May 07, 2021 $79.40 $82.80 $75.92 $76.49 786 176
May 06, 2021 $73.50 $76.72 $70.25 $76.55 2 043 209
May 05, 2021 $79.93 $81.75 $76.59 $77.73 602 271
May 04, 2021 $83.85 $83.85 $77.79 $79.73 829 461
May 03, 2021 $89.84 $90.16 $84.75 $85.11 761 919
Apr 30, 2021 $87.35 $91.50 $86.00 $87.39 1 242 208
Apr 29, 2021 $93.60 $93.93 $84.71 $85.87 1 008 052
Apr 28, 2021 $91.87 $93.09 $88.20 $92.09 695 913
Apr 27, 2021 $91.51 $93.83 $88.81 $92.52 1 016 640
Apr 26, 2021 $87.89 $94.96 $86.62 $92.01 1 030 052
Apr 23, 2021 $84.01 $88.38 $83.14 $85.34 708 725
Apr 22, 2021 $85.03 $88.99 $82.34 $84.23 824 527
Apr 21, 2021 $77.10 $84.39 $75.72 $84.24 514 144
Apr 20, 2021 $79.36 $82.10 $75.51 $78.18 686 936
Apr 19, 2021 $79.47 $82.43 $77.50 $79.65 505 792
Apr 16, 2021 $84.81 $84.81 $79.76 $81.17 536 840
Apr 15, 2021 $85.36 $87.61 $83.18 $84.40 686 762
Apr 14, 2021 $79.69 $88.17 $79.31 $84.73 1 280 192
Apr 13, 2021 $75.01 $79.96 $73.92 $78.91 1 051 880
Apr 12, 2021 $77.47 $77.91 $72.58 $75.00 1 129 766
Apr 09, 2021 $78.32 $80.80 $76.17 $77.99 778 337
Apr 08, 2021 $76.55 $79.75 $76.31 $79.01 553 085
Apr 07, 2021 $80.11 $80.72 $74.96 $75.70 739 605
Apr 06, 2021 $81.86 $82.92 $79.88 $80.10 613 324
Apr 05, 2021 $83.38 $87.04 $81.75 $83.66 646 678
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT